• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Annals of Long Term Care

  • Follow us on

Search

  • Home
  • ARCHIVES
    • Issues
    • Supplements/Webcasts
  • About Us
    • Mission Statement
    • Editorial Description
    • Editorial Board
    • Publishing Staff
    • Our Partners
    • AGS Affiliations
    • Reprints/Permissions
  • SUBMIT
    • Author Guidelines
    • Copyright Transfer Form
    • Author Disclosure Form
    • Submit Now
  • CONTACT
  • ADVERTISING
    • Print Rate Card
    • Online Rate Card
    • Classified Rate Card
    • Sales Contacts
  • Supplements/Special Projects
  • Journal News
  • WEBCASTS
    • Facing Postherpetic Neuralgia in LTC
    • Treatment for Postherpetic Neuralgia Pain
    • Case Study—LTC Patient Suffering from PHN

Abstracts from the Journal of the American Geriatrics Society

  • Fri, 9/11/09 - 8:27am
  • 0 Comments
  • 2179 reads
Citation: 

Pages 44 - 46


Serum Parathyroid Hormone Levels Predict Falls in Older Adults with Diabetes Mellitus

Denise K. Houston, PhD, Ann V. Schwartz, PhD, Jane A. Cauley, DrPH, Frances A. Tylavsky, DrPH, Eleanor M. Simonsick, PhD, Tamara B. Harris, MD, Nathalie de Rekeneire MD, Gary G. Schwartz, PhD, and Stephen B. Kritchevsky, PhD, for the Health, Aging and Body Composition Study

OBJECTIVES: To examine the association between serum parathyroid hormone (PTH) levels and incident falls in older adults with diabetes mellitus.

DESIGN: Longitudinal analysis of incident falls over 1 year in a substudy of participants with diabetes mellitus in the Health, Aging and Body Composition Study.

SETTING: Pittsburgh, Pennsylvania, and Memphis, Tennessee.

PARTICIPANTS: Well-functioning, community-dwelling black and white adults aged 70 to 79 with diabetes mellitus (N=472).

MEASUREMENTS: Measured baseline serum PTH. Self-report of falls over the subsequent 12 months. Baseline physical performance and self-reported demographic, behavioral, and health status measures including kidney function, chronic conditions, and medication use.

RESULTS: One-third (30.3%) of participants reported falling over 1 year of follow-up. Mean baseline serum PTH was 53.5±30.0 pg/mL in nonfallers and 62.6±46.2 pg/mL in fallers (P=.01). For every 1 standard deviation (36 pg/mL) increment in baseline serum PTH, there was approximately a 30% greater likelihood of reporting a fall in the subsequent year, after adjusting for age, sex, race, field center, alcohol consumption, body mass index, physical activity, and winter or spring season (adjusted odds ratio (aOR)=1.30, 95% confidence interval (CI)=1.06–1.59). Further adjustment for kidney function, chronic conditions, medication and supplement use, and physical performance attenuated the association slightly (aOR=1.26, 95% CI=1.01–1.58). A trend remained after additional adjustment for reported falls in the previous year.

CONCLUSION: Higher serum PTH was associated with incident falls in older, well-functioning men and women with diabetes mellitus. Further investigation aimed at understanding the underlying mechanism for the association between serum PTH and falls is needed. J Am Geriatr Soc 2008;56(11):2027-2032.

______________________

Views of Older Persons with Multiple Morbidities on Competing Outcomes and Clinical Decision-Making

Terri R. Fried, MD, Sarah McGraw, PhD, Joseph V. Agostini, MD, and Mary E. Tinetti, MD

OBJECTIVES: To examine the ways in which older persons with multiple conditions think about potentially competing outcomes in order to gain insight into how processes to elicit values regarding these outcomes can be grounded in the patient's perspective.

DESIGN: Qualitative study consisting of purposefully sampled focus groups.

SETTING: Community.

PARTICIPANTS: Persons aged 65 and older taking five or more medications.

MEASUREMENTS: Participants were asked their perceptions about whether their illnesses or treatment interacted with each other, goals of their treatment, and decisions to change or stop treatment.

RESULTS: Although participants were largely unaware that treatment of one condition could worsen another, many had experience with adverse medication effects as a competing outcome. Participants initially discussed their conditions in terms of disease-specific outcomes, such as achieving a target blood pressure or lipid level. In the context of decision-making, participants shifted their discussion from disease-specific to global, cross-disease health outcomes, such as survival, preservation of physical function, and relief of symptoms. Despite having some misconceptions regarding the likelihood of these outcomes, they weighed the outcomes against one another to consider what was most important to them.

image description image description
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »



Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

LATEST NEWS

  • FDA Finally Approves Once-Weekly Type 2 Diabetes Treatment
    [Amylin] 1-31-12
  • FDA approves Voraxaze to treat patients with toxic methotrexate levels
    [FDA] 1-17-12
  • FDA approves first generic version of cholesterol-lowering drug Lipitor
    [FDA] 11-30-11
  • AHRQ Awards $34 Million To Expand Fight Against Healthcare-Associated Infections
    [AHRQ] 11-17-11
more »

Poll

Are nutritional supplements underutilized in long-term care?:

Classified/Recruitment Opportunities

  • Advertise Your Job Here
more »

ALTC Blogs

Getting the Most Out of Your Continuing Medical Education Classes

Neil Baum MD
2/8/12 | 0 Comments | 7 reads

February is American Heart Month

Alvin B Lin MD FAAFP
2/7/12 | 0 Comments | 26 reads

How to Create Collegiality in a Difference of Opinion: Part 2

Neil Baum MD
2/6/12 | 0 Comments | 35 reads
more »
banner banner banner banner banner
HMP Communications © 2012 HMP Communications
  • Home
  • About Us
  • Other Publications
  • Contact Us
  • Privacy Policy

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. © 2012 HMP Communications